LAZZARI, ELISA
LAZZARI, ELISA
Dipartimento di Scienze della Salute
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
2020 M. Colombo, S. Garavelli, M. Mazzola, N. Platonova, D. Giannandrea, R. Colella, L. Apicella, M. Lancellotti, E. Lesma, S. Ancona, M.T. Palano, M. Barbieri, E. Taiana, E. Lazzari, A. Basile, M. Turrini, A. Pistocchi, A. Neri, R. Chiaramonte
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis
2018 M. Colombo, N. Platonova, M. Mazzola, S. Garavelli, M. Barbieri, D. Giannandrea, M.T. Palano, E. Lazzari, A. Basile, A.S. Pistocchi, A. Neri, R. Chiaramonte
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model
2018 M. Colombo, M. Mazzola, R. Colella, S. Garavelli, M. Palano, M. Barbieri, E. Lazzari, D. Giannandrea, N. Platonova, A. Neri, A. Pistocchi, R. Chiaramonte
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system
2018 M. Colombo, M. Mazzola, M. Barbieri, N. Platonova, M.T. Palano, S. Garavelli, D. Giannandrea, E. Lazzari, A. Basile, A.S. Pistocchi, A. Neri, R. Chiaramonte
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment
2017 M. Colombo, S. Galletti, S. Garavelli, R. Colella, F. Baccianti, N. Platonova, M. Palano, E. Lazzari, K. Thümmler, K. Todoerti, L.A. Crews, C.H.M. Jamieson, C. Goodyear, A. Neri, R. Chiaramonte
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
2017 E. Lazzari, P. Mondala, N. Santos, A. Miller, G. Pineda, Q. Jiang, H. Leu, S. Ali, A. Ganesan, C. Wu, C. Costello, M. Minden, R. Chiaramonte, A. Stewart, L. Crews, C. Jamieson
The role of notch pathway in multiple myeloma associated drug resistance
2017 S. Garavelli, E. Lazzari, M. Colombo, N. Platonova, M.T. Palano, F. Baccianti, S. Galletti, A. Neri, L..A. Crews, C.H. Jamieson, R. Chiaramonte
The Notch pathway drives the ability of the bone marrow niche to promote RNA editing in multiple myeloma
2017 M. Colombo, C. Raffaella, M. Barbieri, B. Francesco, E. Lazzari, K. Todoerti, C. Leslie, J.C. H. M., A. Neri, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2016 S. Garavelli, E. Lazzari, M. Colombo, M.T. Palano, F. Baccianti, F. Farris, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte
ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies
2016 E. Lazzari, L. Crews, C. Wu, H. Leu, S. Ali, R. Chiaramonte, M. Minden, C. Costello, C.H.M. Jamieson
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
2016 M. Colombo, S. Galletti, G. Bulfamante, M. Falleni, D. Tosi, K. Todoerti, E. Lazzari, L.A. Crews, C.H.M. Jamieson, S. Ravaioli, F. Baccianti, S. Garavelli, N. Platonova, A. Neri, R. Chiaramonte
Notch signaling drives myeloma cells homing to the bone marrow by regulating the CXCR4/CXCL12 axis
2015 M. Colombo, L. Mirandola, N. Platonova, L. Apicella, D. Berta, M. Lancellotti, E. Lazzari, E. Cobos, M. Chiriva Internati, R. Chiaramonte
Multiple myeloma-associated drug resistance : targeting the Notch pathway
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Notch signaling dysregulation promotes multiple myeloma-associated bone disease
2015 S. Garavelli, M. Colombo, K. Thümmler, L. Apicella, M. Lancellotti, E. Lazzari, K. Todoerti, R. Soutar, N. Platonova, M. Akbar, C. Goodyear, A. Neri, R. Chiaramonte
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology
2015 M. Colombo, S. Garavelli, K. Thümmler, E. Lazzari, K. Todoerti, A. Moschini, L. Cantone, S. Galletti, N. Platonova, A. Paoli, G. Bulfamante, M. Falleni, D. Tosi, V. Bollati, L.A. Crews, C.S. Goodyear, C.H. Jamieson, A. Neri, R. Chiaramonte
MECHANISMS OF DRUG-ESCAPE AND RELAPSE IN MULTIPLE MYELOMA: INTERPLAY BETWEEN ADAR1 AND NOTCH IN ABERRANT RNA EDITING
2015 E. Lazzari
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia
2015 N. Platonova, E. Vigolo, G. Cermisoni, D. De Simone, M. Colombo, S. Garavelli, E. Lazzari, S. Galletti, A. Paoli, A. Neri, R. Chiaramonte
Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor
2015 E. Lazzari, L. Crews, C. Wu, C. Leu, R. Chiaramonte, M. Minden, C. Costello, C. Jamieson
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation
2015 N. Platonova, T. Manzo, L. Mirandola, M. Colombo, E. Calzavara, E. Vigolo, G.C. Cermisoni, D.D. Simone, S. Garavelli, V. Cecchinato, E. Lazzari, A. Neri, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte